Showing results (1-10 of 40) with videos related to
Sort By:
Pageof 4
Kyobu Geka. the Japanese Journal of Thoracic Surgery|October 20, 2010
[Surgical treatment for recurrent pulmonary carcinoma including same and different cell types]Noriyuki Takahashi, Kazunori Tsunematsu, Akihiro Suzuki, et al.Pancreas|April 1, 2008
Interleukin 22 receptor 1 expression in pancreas isletsMakoto Shioya, Akira Andoh, Satoe Kakinoki, et al.Scandinavian Journal of Gastroenterology|July 12, 2008
Germinated barley foodstuff ameliorates inflammation in mice with colitis through modulation of mucosal immune systemOsamu Kanauchi, Tsuyoshi Oshima, Akira Andoh, et al.Cureus|March 7, 2025
Salvage Surgery for Epidermal Growth Factor Receptor-Mutant Lung Cancer With Osimertinib Resistance: A Case ReportShinya Otsuka, Yutaro Nagano, Makoto Shioya, et al.Molecular Medicine Reports|April 12, 2011
Increased number of FoxP3+CD4+ regulatory T cells in inflammatory bowel diseaseHiromitsu Ban, Akira Andoh, Makoto Shioya, et al.World Journal of Gastroenterology|September 9, 2008
Mucosal cytokine network in inflammatory bowel diseaseAkira Andoh, Yuhki Yagi, Makoto Shioya, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|February 2, 2008
Phosphatidylinositol 3-kinase/Akt signaling mediates interleukin-32alpha induction in human pancreatic periacinar myofibroblastsAtsushi Nishida, Akira Andoh, Makoto Shioya, et al.Cancer Chemotherapy and Pharmacology|May 16, 2013
Pharmacokinetic interaction between sorafenib and prednisolone in a patient with hepatocellular carcinomaSatoshi Noda, Makoto Shioya, Daiki Hira, et al.World Journal of Gastroenterology|October 16, 2008
FR167653, a p38 mitogen-activated protein kinase inhibitor, aggravates experimental colitis in miceTakashi Nishimura, Akira Andoh, Atsushi Nishida, et al.Thoracic Cancer|February 12, 2020
Long-term response with durvalumab after chemoradiotherapy for pulmonary pleomorphic carcinoma: A case reportTakafumi Yorozuya, Tetsuya Taya, Kento Yasuda, et al.Pageof 4